Neumora Therapeutics (NMRA) Cash & Current Investments (2022 - 2026)
Neumora Therapeutics (NMRA) posted Cash & Current Investments of $116.83 million for Q2 2026, down 46.3% from $217.59 million a year earlier and down 20.6% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Cash & Current Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Neumora Therapeutics' Cash & Current Investments came in at $182.53 million, down 40.7% from FY2024.
- Annual Cash & Current Investments shows a three-year compound annual growth rate of -21.1% (FY2022 to FY2025).
- In prior years, Neumora Therapeutics' Cash & Current Investments was $307.58 million in FY2024 (-32.2%), $453.98 million in FY2023 (+22.1%) and $371.88 million in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Cash & Current Investments in data going back to Q3 2022.
- On a year-over-year basis, Cash & Current Investments has declined in each of the last eight quarters, with an average decline of 40.7% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2023, with growth of 101.8%; the weakest was Q3 2025, with a decline of 49.7%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $147.07 million (Q1 2026), $182.53 million (Q4 2025) and $171.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Neumora Therapeutics | 73.19 Mn | -544.77 Mn | - | 116.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 116.83 Mn |
| Mar 31, 2026 | 147.07 Mn |
| Dec 31, 2025 | 182.53 Mn |
| Sep 30, 2025 | 171.53 Mn |
| Jun 30, 2025 | 217.59 Mn |
| Mar 31, 2025 | 249.35 Mn |
| Dec 31, 2024 | 307.58 Mn |
| Sep 30, 2024 | 341.31 Mn |
| Jun 30, 2024 | 371.64 Mn |
| Mar 31, 2024 | 422.72 Mn |
| Dec 31, 2023 | 453.98 Mn |
| Sep 30, 2023 | 509.57 Mn |
| Jun 30, 2023 | 204.22 Mn |
| Mar 31, 2023 | 210.87 Mn |
| Dec 31, 2022 | 371.88 Mn |
| Sep 30, 2022 | 252.51 Mn |
API Access
Neumora Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();